News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Daily News ASCVD and Cancer Diagnoses Pose Potentially Deadly Costs to Patients Caitlin E. Cox June 16, 2021
News Daily News Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement Yael L. Maxwell April 26, 2021
News Daily News Primary PCI Underused but Just as Effective in Cancer Patients With STEMI Michael O'Riordan February 04, 2021